How do operational requirements differ between commercial and non-commercial studies?
Biostat® delivers both commercial and non-commercial (academic/grant-funded) studies, and we understand their unique operational, formal and financial characteristics.
Commercial studies
• Sponsored by pharmaceutical, biotech or medical device companies.
• Aim to register, expand indications or bring a new formulation to market.
• Typically have larger budgets and strict timelines due to business goals.
• Operate within extensive Quality Management Systems and RBQM frameworks.
• Use full technological infrastructure: eCRF, IWRS, CTMS, eTMF, central labs, vendor networks.
• Require detailed procedures (SOPs), monitoring, reporting and audits.
Non-commercial studies
• Conducted by academic institutions, clinical hospitals or scientific societies.
• Aim to expand medical knowledge or compare diagnostic/therapeutic methods.
• Funded by grants (ABM, NCBR, EU programmes).
• Have smaller budgets and limited operational resources.
• Often lack full QMS and require CRO support in building operational structure.
Biostat® strengthens these projects by providing:
• dedicated eCRF platforms compliant with grant requirements,
• clinical monitoring and audits,
• quality management documents and GCP support,
• logistics for IMP/medical devices,
• simplified SOP frameworks and document registers.
Although both types of studies share the same core documents — protocol, SAP, CRF, monitoring plan, final report — their level of detail and operational implementation differ.
Commercial sponsors receive full CRO operational support with vendor oversight, enterprise-grade systems and comprehensive reporting.
Academic sponsors receive a streamlined, cost-efficient structure that remains fully GCP-compliant while fitting within grant limitations.
Because Biostat® operates in both environments, we can advise on the most appropriate model for your objectives — scientific or commercial — and ensure smooth and effective study execution.
